Flexeril vs Soma: Serotonergic Brainstem Relaxation vs GABAA Sedation
Flexeril (Cyclobenzaprine) and Soma (Carisoprodol) are two of the most widely prescribed skeletal muscle relaxants in the United States. Flexeril works predominantly at the brainstem level to reduce tonic somatic motor activity, relieving spasms without interacting with benzodiazepine or opioid receptors. Soma, by comparison, undergoes hepatic conversion into meprobamate—a potent sedative that acts directly on GABAA receptors. While Soma provides rapid relief for severe spasms, Flexeril is markedly safer for patients who wish to avoid habit-forming substances.
Feature-by-Feature Comparison
Flexeril
Soma
| Feature / Capability | Flexeril | Soma |
|---|---|---|
| Active Chemical | Cyclobenzaprine Hydrochloride | Carisoprodol |
| Primary Site of Action | Brainstem (Inhibits descending motor pathways) | Spinal cord & GABAA receptor modulation |
| DEA Controlled Schedule | Non-controlled (Zero DEA schedule) | Schedule IV controlled substance |
| Risk of Dependence | Negligible risk of physical addiction | Moderate-to-high risk (Metabolizes to meprobamate) |
| Indication | Acute muscle spasms & fibromyalgia tension | Severe acute musculoskeletal pain |
| Duration | 12 to 24 hours | 4 to 6 hours |
| Starting Price | $85.00 – $210.00 | $105.00 – $250.00 |
| View Flexeril | View Soma |
The Final Verdict
Flexeril is the preferred first-line muscle relaxant for long-term safety because it is non-controlled and non-addictive. Soma provides more pronounced immediate tranquilization but carries significant dependency risks because it metabolizes into meprobamate.
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. The accuracy of pricing and features may change over time. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication.
Last updated: September 2026